Cas:58011-68-0 pyrazolate manufacturer & supplier

Chemical Name:pyrazolate

CAS.NO:58011-68-0

Synonyms:(2,4-dichlorophenyl)[1,3-dimethyl-5-[[(4-methylphenyl)sulfonyl]oxy]-1H-pyrazol-4-yl]methanone;Pyrazolynate;PYRAZOLATE;MFCD00274603;SW-751;4-(2,4-dichlorobenzoyl)-1,3-dimethylpyrazol-5-yl toluene-4-sulfonate;4-(2,4-dichlorobenzoyl)-1,3-dimethyl-1H-pyrazol-5-yl 4-methylbenzene-1-sulfonate;[4-(2,4-dichlorobenzoyl)-2,5-dimethylpyrazol-3-yl] 4-methylbenzenesulfonate

Molecular Formula:C₁₉H₁₆Cl₂N₂O₄S

Molecular Weight:439.31200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:610.7ºC at 760 mmHg

Density:1.42g/cm3

Index of Refraction:1.632

PSA:86.64000

Exact Mass:438.02100

LogP:5.42320

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like (2,4-dichlorophenyl)[1,3-dimethyl-5-[[(4-methylphenyl)sulfonyl]oxy]-1H-pyrazol-4-yl]methanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[4-(2,4-dichlorobenzoyl)-2,5-dimethylpyrazol-3-yl] 4-methylbenzenesulfonate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[4-(2,4-dichlorobenzoyl)-2,5-dimethylpyrazol-3-yl] 4-methylbenzenesulfonate Use and application,MFCD00274603 technical grade,usp/ep/jp grade.

Related News: That site will also tap robotics and virtual reality training, which Takeda says should help operators “learn in a virtual environment before they enter the real facility.” 3-((E)-7-Methoxy-3,7-dimethyl-oct-2-enyloxy)-N-p-tolyl-butyramide manufacturers As for the consumer health unit, GSK plans to demerge it by mid-2022, during which GSK will shed at least 80% of its 68% holding in the JV to shareholders. (2-Benzoyl-4-chloro-phenoxy)-acetic acid hydrazide suppliers the strategy lays out the challenges that researchers and institutions are facing, including skills shortages in particular disciplines, limited opportunities for career progression and issues of bullying and harassment. 2-(2-butoxy-3-methoxy-phenyl)-4-oxo-3,4-dihydro-quinazoline-6-carboxylic acid vendor & factory As for the consumer health unit, GSK plans to demerge it by mid-2022, during which GSK will shed at least 80% of its 68% holding in the JV to shareholders.,That site will also tap robotics and virtual reality training, which Takeda says should help operators “learn in a virtual environment before they enter the real facility.”